Lonza will employ more than 200 full-time staff to work at the Texas-based facility, the company says.

Three weeks after Hurricane Maria hit the island, pharmaceutical plants are not back up to speed.

Turing Pharmaceuticals will soon offer discounts to hospitals for its toxoplasmosis-fighting drug, the company announced, but some say the proposed price reductions are not enough.

A Japanese newspaper claims that the pharma giant funded flawed research that revealed extra health benefits for one of its top-selling drugs.

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

Pharma company publishes a list of 17 companies known to have sold the incorrect isomer of the kinase inhibitor bosutinib.

An incorrect isomer of the kinase inhibitor bosutinib is circulating in the biomedical research community, potentially throwing doubt on study results.

Legislation proposes speeding certain drug applications submitted to the US Food and Drug Administration.